NEWS

Opening our new facility

2025 marks a major milestone for the Medi-Radiopharma family – we're celebrating 30 years of innovation in nuclear medicine and preparing to open our brand-new manufacturing facility following FDA and EMA certification by the end of the year!

The new site spans 6,000 m² (64,500 sqft) and will significantly expand our production capacity to 3.5 million vials per year – a major leap forward to meet growing global demand.

This significant expansion strengthens our research and development capabilities and our CDMO services enabling us to deliver comprehensive solutions for liquid and lyophilized products.

Be our partner and discover our complete end-to-end solutions:

• CDMO service for liquid and Lyophilized Products: Scalable batch production ranging from 1 to 300 liters.
• Comprehensive Tech Transfer & validation: including microbiologycal, analytical, radioanalytical controls and stability testings.
• Lisense for all isotopes  (including α-Emitters)
• Analytical Method Development & Validation: For both active drug subtances and inactive/ radioactive pharmaceutical products
• Drog Product Development: QbD-driven formulation and process development for liquid and lyophilized injections, including validation and scale up
• API Synthesis: Small molecule API synthesis under GMP compliance
• Animal testing biodistribution studies and related imaging
• Regulatory Services: Comlete Support from eCTD preparation through regulatory approval

We look forward to this new chapter and to continuing our commitment to innovation, quality, and global healthcare solutions.

Watch the video to get a first taste of the new site! To learn more, reach out to k.kis@mediradiopharma.hu